Le Lézard
Classified in: Health
Subject: PER

Appointment of Dr. Stanley Vollant to Santé Québec Board of Directors: At the Crossroads Towards Improved Access for All


WENDAKE, QC, May 22, 2024 /CNW/ - The First Nations of Quebec and Labrador Health and Social Services Commission (FNQLHSSC) is proud of the appointment of Dr. Stanley Vollant, Public Health Physician Advisor for the FNQLHSSC, to the Board of Directors of Santé Québec, the new state-owned corporation that aims to improve access to the health and social services system as well as the patient experience. His vast experience and knowledge of First Peoples will benefit all Quebec society and will undoubtedly help Santé Québec to achieve this objective.

"I am ready to take on this new challenge in collaboration with the other members of the Board of Directors, and I look forward to the positive changes that I will be able to assist in bringing about for the benefit of the entire population while giving my First Nations brothers and sisters a voice," said Stanley Vollant.

"This nomination means an important step towards exercising our self-determination in health and social services by giving a voice to our people and ensuring that the priorities are also developed on First Nations' worldview," added Derek Montour, President of the FNQLHSSC Board of Directors.

Santé Québec Board of Directors is made up of 15 members, as provided for in the Act respecting the governance of state-owned enterprises and the Loi sur la gouvernance du système de santé et de services sociaux.

SOURCE First Nations of Quebec and Labrador Health and Social Services Commission


These press releases may also interest you

at 18:00
The University of California, Irvine has received a $50 million donation from Orange County biotech entrepreneur Charlie Dunlop for the School of Biological Sciences. His gift will create an endowed fund that will provide unrestricted support for...

at 15:40
Please be advised that the Honourable Patty Hajdu, Minister of Indigenous Services, will make a funding announcement for the Weeneebayko Area Health Authority. Date:  Monday, June 17, 2024Time: 12:00 p.m. (ET) Where:House of Commons Foyer (West...

at 12:45
SummaryProducts: Dianeal PD4 2.5% Dextrose peritoneal dialysis solution (3,000 mL and 5,000 mL); Physioneal 40 2.27% Glucose peritoneal dialysis solution (2,500 mL)Issue: Health products ? Product safetyWhat to do: Immediately check your stock to see...

at 10:45
Pomerantz LLP announces that a class action lawsuit has been filed against Altimmune, Inc. ("Altimmune" or the "Company") and certain officers. The class action, filed in the United States District Court for the District of Maryland, Southern...

at 10:30
IASO biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, presented clinical data on the use of Equecabtagene Autoleucel (Eque-cel),...

at 10:05
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today statistically significant and clinically meaningful results from its Phase III STARGLO study of Columvi® (glofitamab-gxbm) in combination with gemcitabine and...



News published on and distributed by: